Skip to content

Efficacy of Pentazocin and diclofenac or the combination in post-caesarean section analgesia.

Randomised Control Trial On Use Of Pentazocin and Diclofenac or the combination in post- caesarean section analgesia.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
PACTR
Registry ID
PACTR202308490615689
Enrollment
180
Registered
2023-08-07
Start date
2023-06-30
Completion date
Unknown
Last updated
2026-09-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pregnancy and Childbirth

Interventions

Pentazocin
diclofenac
Diclofenac and Pentazocin

Sponsors

Egwim Adanna Vivian
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: Inclusion criteria were pregnant women scheduled for emergency or elective caesarean section under spinal anaesthesia and women with ASA class I-II clinical status.

Exclusion criteria

Exclusion criteria: Allergy to diclofenac or pentazocin Those that had general anaesthesia History of asthma Active gastrointestinal bleeding or peptic ulcer Long term steroids therapy Mentally disabled and unconscious patients Surgery lasting more than 99 minutes Refusal to participate

Design outcomes

Primary

MeasureTime frame
Post operative pain scores

Secondary

MeasureTime frame
Need for additional analgesic

Countries

Nigeria

Contacts

Public ContactJideuma Ikenna Egwim

PHD Epidemiology

jidegwim@yahoo.com+2348033187641

Outcome results

None listed

Source: PACTR (via WHO ICTRP) · Data processed: Sep 19, 2026